Information  X 
Enter a valid email address


  Print          Annual reports

Tuesday 05 January, 2021


Exercise of warrants

RNS Number : 5159K
05 January 2021

5 January 2021



("EQTEC", the "Company" or the "Group")


Exercise of warrants

Total Voting Rights


EQTEC plc (AIM: EQT), a world leading gasification technology solutions company for sustainable waste-to-energy projects, announces the exercise of certain warrants to subscribe for new ordinary shares in the Company ("New Ordinary Shares").


Exercise of warrants


Warrants over 12,000,000 New Ordinary Shares at a price of 0.25 pence per share and warrants over 30,773,543  New Ordinary Shares at a price of 0.33 pence per share have been exercised. The aggregate gross proceeds of these exercises receivable by the Company amount to £131,553.


Admission and Total Voting Rights


The Company will make an application to the London Stock Exchange plc for the 42,773,543 New Ordinary Shares, to be issued and allotted as a result of the warrant exercises set out above, to be admitted to trading on AIM ("Admission").  It is expected that Admission will become effective and dealings will commence on or around 8 January 2021.  The 42,773,543 New Ordinary Shares will rank pari passu with the existing Ordinary Shares.


Following Admission, there will be 7,027,485,849 Ordinary Shares in issue. This number may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.


This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.




+353 21 2409 056

David Palumbo / Gerry Madden

Strand Hanson - Nomad & Financial Adviser

+44 20 7409 3494

James Harris / James Dance / Jack Botros

Arden Partners - Broker

+44 20 7614 5900

Paul Shackleton (Corporate) / Simon Johnson (Sales)

Maitland/AMO - Strategic Communications & PR/IR adviser

+44 20 7379 5151

James Benjamin

[email protected]


About EQTEC plc

EQTEC is a world leading advanced gasification technology partner with proven proprietary patented technology for waste-to-value applications.


EQTEC designs and supplies advanced gasification solutions that have a higher efficiency product offering and are modular and scalable from 1MW to 25MW. EQTEC's versatile solutions are independently proven to process over 50 different types of feedstock, including municipal waste, agricultural waste, biomass and plastics with no hazardous waste or toxic emissions . EQTEC's solutions produce a uniquely pure high-quality synthesis gas (syngas), that is capable of being used for the widest applications in the creation of energy, hydrogen and biofuels.


Proprietary technology design together with deployment and maintenance capabilities mitigate the risks when using third party equipment. EQTEC's Technology Integration capabilities enable the Group to lead collaborative ecosystems that build sustainable, waste elimination and green energy infrastructure.


The Company is quoted on AIM (ticker: EQT) and the London Stock Exchange awarded EQTEC the Green Economy Mark that recognises listed companies with 50% or more of revenues from environmental/green solutions.


Further information on the Company can be found at






This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t